Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.064 | 0.7 |